In Silico Technologies in Drug Target Id

In Silico Technologies in Drug Target Id
Pris
459,-
E-Bok
E-bøkene legges i din ARK-leseapp. Bøkene kan også lastes ned fra Din side.
×
Logg deg inn for å gjennomføre dette kjøpet med ett klikk!

Etter at kjøpet er gjennomført vil boken være tilgjengelig på «din side» og i ARK-appen
Format E-Bok
Kopisperre Teknisk DRM
Filformat PDF
Utgivelsesår 2006
Forlag CRC Press
Språk Engelsk
ISBN 9781420015737
Se flere detaljer  

Om In Silico Technologies in Drug Target Id

The pharmaceutical industry relies on numerous well-designed experiments involving high-throughput techniques and in silico approaches to analyze potential drug targets. These in silico methods are often predictive, yielding faster and less expensive analyses than traditional in vivo or in vitro procedures. In Silico Technologies in Drug Target Identification and Validation addresses the challenge of testing a growing number of new potential targets and reviews currently available in silico approaches for identifying and validating these targets. The book emphasizes computational tools, public and commercial databases, mathematical methods, and software for interpreting complex experimental data. The book describes how these tools are used to visualize a target structure, identify binding sites, and predict behavior. World-renowned researchers cover many topics not typically found in most informatics books, including functional annotation, siRNA design, pathways, text mining, ontologies, systems biology, database management, data pipelining, and pharmacogenomics. Covering issues that range from prescreening target selection to genetic modeling and valuable data integration, In Silico Technologies in Drug Target Identification and Validation is a self-contained and practical guide to the various computational tools that can accelerate the identification and validation stages of drug target discovery and determine the biological functionality of potential targets more effectively. Daniel E. Levy, editor of the Drug Discovery Series, is the founder of DEL BioPharma, a consulting service for drug discovery programs. He also maintains a blog that explores organic chemistry.


Kundevurderinger

ARKs anbefalinger

Det finnes ingen vurderinger av dette produktet. Skriv anmeldelse

Anbefalt


Tips en venn